BTK Inhibitor Use Proves Beneficial in Mantle Cell Lymphoma Treatment
Typically, the longer a patient with cancer is exposed to a drug the more side effects they experience, but in the case of Imbruvica, the opposite appears to be true for patients with MCL.
Read More